<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: August 3, 2000
(Date of earliest event reported)
TREGA BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-27972 51-0336233
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
9880 Campus Point Drive, San Diego, CA 92121
(Address of principal executive offices) (Zip Code)
(858) 410-6500
(Registrant's telephone number, including area code)
<PAGE>
ITEM 5. OTHER EVENTS
Attached hereto as Exhibit 99.1 and incorporated by reference herein is
financial information for Trega Biosciences, Inc. for the quarter ended June 30,
2000 and forward-looking statements relating to the second half of 2000 as
presented in a press release of August 3, 2000.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
99.1 Financial information for Trega Biosciences, Inc. for the
quarter ended June 30, 2000 and forward-looking statements
relating to the second half of 2000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
TREGA BIOSCIENCES, INC.
(Registrant)
Date: August 4, 2000 By: /s/ MICHAEL G. GREY
-------------------------------------
Michael G. Grey
President and Chief Executive Officer
